Firefly Neuroscience (AIFF) Invested Capital (2020 - 2026)

Firefly Neuroscience has reported Invested Capital for 7 years, with the latest figure at $15.1 million in Q2 2026.

• On a quarterly basis, Invested Capital rose 20.38% year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 20.38% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, up 608.12% from the prior year.
• Invested Capital was $15.1 million for Q2 2026 at Firefly Neuroscience, up from $8.9 million in the prior quarter.
• The five-year high for Invested Capital was $15.1 million in Q2 2026, with the low at -$1.8 million in Q4 2022.
• Average Invested Capital over 5 years is $4.4 million, with a median of $2.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Invested Capital sank 110.33% in 2022, then surged 1474.64% in 2025.
• Over 5 years, Invested Capital stood at -$1.8 million in 2022, then soared by 106.05% to $109000.0 in 2023, then jumped by 951.38% to $1.1 million in 2024, then surged by 608.12% to $8.1 million in 2025, then surged by 86.58% to $15.1 million in 2026.
• The last three Invested Capital figures came in at $15.1 million (Q2 2026), $8.9 million (Q1 2026), and $8.1 million (Q4 2025), per Business Quant data.